EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Metabolic Dysregulation in Obesity and Metabolic Syndrome: The Emerging Role of N-Acetylcysteine

Dorota Magdalena Radomska-Leśniewska, Justyna Niderla-Bielińska, Marek Kujawa, Ewa Jankowska-Steifer

Metabolites · 26.09.2025 · 15 (10) · 645

DOI: 10.3390/metabo15100645 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 26.09.2025. Verfasst von Dorota Magdalena Radomska-Leśniewska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Faculty of Medicine, Medical University of Warsaw, Chalubinskiego 5 Str, 02-004 Warsaw, Poland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity and metabolic syndrome (MetS), growing global health concerns, are closely linked to the development of insulin resistance, type 2 diabetes, steatotic liver disease, and cardiovascular diseases (CVDs). An increase in visceral adipose tissue, the main symptom of MetS, contributes to systemic metabolic dysfunction, resulting in disturbances in glucose and lipid metabolism, mitochondrial dysfunction, and redox imbalance, which creates a vicious cycle of inflammation and oxidative stress, accelerating comorbidities. N-acetylcysteine (NAC), a precursor to glutathione, with antioxidant and anti-inflammatory properties, is described as a potent metabolic modulator that restores metabolic homeostasis. NAC’s ability to modulate oxidative stress and inflammation may be particularly valuable in preventing or mitigating cardiovascular complications of MetS. The aim of this narrative review is to summarize current evidence from cellular, animal, and human studies on NAC’s impact on metabolic health. MetS affects nearly one-third of the global population; therefore, there is a pressing need for accessible therapeutic strategies. NAC appears to offer potential benefits as an adjunctive agent for individuals with metabolic disturbances, but further research is needed to confirm its efficacy and establish its role in clinical practice.

Schlagwörter

Stichwörter der Autor:innen

NACatherosclerosiscardiovascular diseasedyslipidemiainsulin resistancemetabolic modulatormetaflammationoxidative stresstype 2 diabetesvisceral fat

Autor:innen und Institutionen

  • Department of Histology and Embryology, Faculty of Medicine, Medical University of Warsaw, Chalubinskiego 5 Str, 02-004 Warsaw, Poland.
  • Department of Histology and Embryology, Faculty of Medicine, Lazarski University, 02-662 Warsaw, Poland.

Zitieren

APA

Radomska-Leśniewska, D. M., Niderla-Bielińska, J., Kujawa, M., & Jankowska-Steifer, E. (2025). Targeting Metabolic Dysregulation in Obesity and Metabolic Syndrome: The Emerging Role of N-Acetylcysteine. Metabolites, 15(10), 645. https://doi.org/10.3390/metabo15100645

Vancouver

Radomska-Leśniewska DM, Niderla-Bielińska J, Kujawa M, Jankowska-Steifer E. Targeting Metabolic Dysregulation in Obesity and Metabolic Syndrome: The Emerging Role of N-Acetylcysteine. Metabolites. 2025;15(10):645. doi:10.3390/metabo15100645

BibTeX
@article{RadomskaLeniewska2025,
  author = {Radomska-Leśniewska, Dorota Magdalena and Niderla-Bielińska, Justyna and Kujawa, Marek and Jankowska-Steifer, Ewa},
  title = {Targeting Metabolic Dysregulation in Obesity and Metabolic Syndrome: The Emerging Role of N-Acetylcysteine},
  journal = {Metabolites},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {645},
  doi = {10.3390/metabo15100645}
}
Kostenlos starten →